摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-O-benzyl-2,3-O-isopropylidene-D-ribofuranose | 198969-39-0

中文名称
——
中文别名
——
英文名称
5-O-benzyl-2,3-O-isopropylidene-D-ribofuranose
英文别名
(3aR,6R,6aR)-2,2-dimethyl-6-(phenylmethoxymethyl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-ol
5-O-benzyl-2,3-O-isopropylidene-D-ribofuranose化学式
CAS
198969-39-0
化学式
C15H20O5
mdl
——
分子量
280.321
InChiKey
YPAOSXPSJGYURT-ZHZAVPAVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    418.9±45.0 °C(Predicted)
  • 密度:
    1.187±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    57.2
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthetic studies toward the preparation of (4R,5R)-(−)-3-[(benzyloxy)methyl]-4,5-O-isopropylidene-cyclopenten-2-one: an important synthetic intermediate for carbanucleosides
    摘要:
    The carbocyclic compound (4R,5R)-(-)-3-[(benzyloxy)methyl]-4,5-O-isopropylidene-2-cyclopentenone 1 is an important synthetic intermediate to access a variety of carbanucleosides. Herein, synthetic studies that lead to this valuable compound employing inexpensive D-ribose as the chiral source are presented. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2004.11.069
  • 作为产物:
    参考文献:
    名称:
    Synthetic studies toward the preparation of (4R,5R)-(−)-3-[(benzyloxy)methyl]-4,5-O-isopropylidene-cyclopenten-2-one: an important synthetic intermediate for carbanucleosides
    摘要:
    The carbocyclic compound (4R,5R)-(-)-3-[(benzyloxy)methyl]-4,5-O-isopropylidene-2-cyclopentenone 1 is an important synthetic intermediate to access a variety of carbanucleosides. Herein, synthetic studies that lead to this valuable compound employing inexpensive D-ribose as the chiral source are presented. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2004.11.069
点击查看最新优质反应信息

文献信息

  • [EN] NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO<br/>[FR] COMPOSITIONS THÉRAPEUTIQUES À BASE DE NUCLÉOTIDES ET NUCLÉOSIDES ET UTILISATIONS ASSOCIÉES
    申请人:UNIV EMORY
    公开号:WO2017155923A1
    公开(公告)日:2017-09-14
    This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.
    这份披露涉及到核苷酸和核苷类治疗组合物,用于治疗传染病、病毒感染和癌症,在这些组合物中,核苷酸或核苷的碱基至少含有一个醇、酮或醚。
  • Highly regioselective and stereoselective synthesis of C-Aryl glycosides <i>via</i> nickel-catalyzed <i>ortho</i>-C–H glycosylation of 8-aminoquinoline benzamides
    作者:Wei-Yu Shi、Ya-Nan Ding、Nian Zheng、Xue-Ya Gou、Zhe Zhang、Xi Chen、Yu-Yong Luan、Zhi-Jie Niu、Yong-Min Liang
    DOI:10.1039/d1cc03589d
    日期:——
    C-Aryl glycosides are of high value as drug candidates. Here a novel and cost-effective nickel catalyzed ortho-CAr–H glycosylation reaction with high regioselectivity and excellent α-selectivity is described. This method shows great functional group compatibility with various glycosides, showing its synthetic potential. Mechanistic studies indicate that C–H activation could be the rate-determining
    C-芳基糖苷作为候选药物具有很高的价值。本文描述了一种新颖且经济高效的催化邻-C Ar -H 糖基化反应,具有高区域选择性和优异的 α-选择性。该方法与各种糖苷表现出良好的官能团相容性,显示出其合成潜力。机理研究表明 C-H 激活可能是速率决定步骤。
  • Titanocene-Catalyzed Reduction of Lactones to Lactols
    作者:Xavier Verdaguer、Marcus C. Hansen、Scott C. Berk、Stephen L. Buchwald
    DOI:10.1021/jo971560s
    日期:1997.11.1
    A convenient method for the conversion of lactones to lactols is described. The hydrosilylation to lactols is carried out via air-stable titanocene difluoride or a titanocene diphenoxide precatalyst using inexpensive polymethylhydrosiloxane (PMHS) as the stoichiometric reductant. These procedures have been demonstrated with a variety of substrates and proceed in good to excellent yield.
    描述了一种方便的将内酯转化为内酯的方法。使用便宜的聚甲基氢硅氧烷(PMHS)作为化学计量的还原剂,通过空气稳定的二茂化物或二茂二苯醚预催化剂进行氢化硅烷化为乳糖醇。这些步骤已在多种底物上得到证明,并且以良好至极好的收率进行。
  • Nickel-catalyzed generation of 2-methylhex-5-enyl ethers from allyl ethers with trimethylaluminium
    作者:Takahiko Taniguchi、Kunio Ogasawara
    DOI:10.1039/a802430h
    日期:——
    Allyl ethers have been converted into the corresponding 2-methylhex-5-enyl ethers in one step on treatment with trimethylaluminium in the presence of a catalytic amount of (dppp)NiCl2.
    丙烯醚在催化量的(dppp)NiCl2存在下,与三甲基铝处理后,已一步转化为相应的2-甲基己-5-烯基醚。
  • Synthesis of methyl 2-O-allyl-(and 3-O-allyl-) 5-O-benzyl-β-d-ribofuranoside
    作者:Trupti Desai、Jill Gigg、Roy Gigg
    DOI:10.1016/0008-6215(95)00308-8
    日期:1996.1
    D-Ribose was converted into methyl 5-O-benzyl-beta-D-ribofuranoside and this, on tin-mediated allylation, gave a mixture of the 2-O-allyl and 3-O-allyl derivatives which were separated by chromatography. The more polar isomer was characterised as the 3-O-allyl derivative after conversion via 3-O-allyl-5-O-benzyl-1,2-O-isopropylidene-alpha-D-ribofuranose (which was also synthesised from 3-O-allyl-1
    D-核糖转化为甲基5-O-苄基-β-D-呋喃呋喃糖苷,并且在介导的烯丙基化中,得到2-O-烯丙基和3-O-烯丙基衍生物的混合物,将其通过色谱法分离。通过3-O-烯丙基-5-O-苄基-1,2-O-异亚丙基-α-D-呋喃核糖转化后,更具极性的异构体被表征为3-O-烯丙基衍生物(也由3- O-烯丙基-1,2-:5,6-二-O-异亚丙基-α-D-呋喃糖)成已知的5-O-苄基-1,2-O-异亚丙基-α-D-呋喃核糖。通过甲基2-O-烯丙基-5-O将3-O-烯丙基-5-O-苄基-β-D-呋喃呋喃糖苷转化为甲基2-O-烯丙基-5-O-苄基-β-D-核呋喃糖苷-苄基-3-O-(丙-1-烯)-β-D-呋喃呋喃糖苷。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫